Docetaxel with androgen deprivation therapy (ADT) and radiotherapy (RT) for high-risk localized prostate cancer (HRLPC): An ICECaP individual patient-data (IPD) meta-analysis of randomized controlled trials (RCTs).

Authors: Praful Ravi, Lucia Kwak, Wanling Xie, Anthony Victor D'Amico, James Dignam, Karim Fizazi, Nicholas David James, Gwenael Le Teuff, Paul Nguyen, Howard M. Sandler, Alton Oliver Sartor, Matthew R. Sydes, Christopher Sweeney

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.5013

Source: Full article

---

Abstract

5013